Filter
365
Text search:
virus
variants
Featured
Recommendations
65
New Publications
26
Language
Document type
Guidelines
108
Studies & Reports
73
No document type
60
Fact sheets
46
Strategic & Response Plan
31
Manuals
22
Videos
8
Training Material
6
Resource Platforms
5
Situation Updates
3
Brochures
2
Infographics
1
Countries / Regions
Global
19
Latin America and the Carribbean
17
Africa
13
India
9
Western and Central Europe
8
Germany
7
Kenya
7
Brazil
7
South Africa
5
East and Southern Africa
5
West and Central Africa
5
Nigeria
4
Niger
4
Malawi
4
Middle East and North Africa
4
Russia
4
Senegal
3
Congo, Democratic Republic of
3
Ethiopia
3
Cameroon
3
South Sudan
3
South–East Asia Region
3
Eastern Europe
3
Spain
3
Burkina Faso
2
Liberia
2
Mali
2
Côte d’Ivoire / Ivory Coast
2
Morocco
2
Haiti
2
Lebanon
2
Turkey
2
Syria
2
Chad
2
Rwanda
2
Mozambique
2
Sudan
2
Peru
2
Bolivia
2
Chile
2
Asia
2
France
2
Tunisia
2
Guinea
1
Sierra Leone
1
Saudi Arabia
1
Ghana
1
Uganda
1
Zimbabwe
1
Philippines
1
Somalia
1
Iraq
1
Jordan
1
Egypt
1
Mauritania
1
Benin
1
Argentina
1
Dominican Republic
1
Eswatini/ Swaziland
1
Cuba
1
Colombia
1
Honduras
1
Ecuador
1
El Salvador
1
Libya
1
Guatemala
1
Madagascar
1
Mexico
1
Nicaragua
1
Yemen
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Venezuela
1
Southern Africa
1
Congo-Brazzaville
1
Qatar
1
Kazakhstan
1
Vietnam
1
Gabon
1
United Kingdom
1
Portugal
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
93
Clinical Guidelines
26
Public Health
17
Key Resources
12
Pharmacy & Technologies
11
Women & Child Health
7
Capacity Building
1
Toolboxes
COVID-19
213
HIV
18
Rapid Response
17
Planetary Health
11
NTDs
10
Ebola
7
TB
7
AMR
6
Global Health Education
5
Health Financing Toolbox
5
Mental Health
4
NCDs
4
Caregiver
3
Refugee
2
Pharmacy
2
Cholera
1
Polio
1
Conflict
1
Zika
1
Specific Hazards
1
The Committee discussed the implications for preparedness for smallpox-like events reflected by the ongoing COVID-19 pandemic. The Committee noted how quickly diagnostics and vaccines could be developed and deployed when resources and political will were abundant. This rapidity was also due to the f
...
Orientations provisoires
9 août 2021
Le présent document vise à décrire un ensemble minimal d'activités de surveillance recommandées au niveau national pour détecter et surveiller la prévalence relative des variantes du SRAS-CoV-2 et à présenter un ensemble d'activités pour la caractér
...
n light of the potential risk posed by SARS-CoV-2 variants, in January 2021 WHO organized an ad hoc consultation to discuss the development of an R&D agenda in response to existing and emerging SARS-CoV-2
...
This document aims to provide interim guidance for microbiology and virology experts, other laboratory professionals, laboratory managers, infectious disease programme managers, public health professionals and other stakeholders that provide primary, confirmatory or advanced testing for SARS-CoV-2,
...
This document aims to describe a minimum set of surveillance activities recommended at the national level to detect and monitor the relative prevalence of SARS-CoV-2 variants and outline a set of activities for the characterization and assessment of
...
Cet article fait partie d’une série de notes explicatives sur la mise au point et la distribution de vaccins.
1 March 2021
This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explained series.
ECDC Technical Report
In line with ECDC’s recommendations provided in the ’Risk Assessment of HTLV-1/2 transmission by tissue/cell transplantation’ dated 14 March 2012, this Directive replaces the term ‘incidence’ with ‘prevalence’ in the description of endemic areas of HTLV-1/2 i ...
In line with ECDC’s recommendations provided in the ’Risk Assessment of HTLV-1/2 transmission by tissue/cell transplantation’ dated 14 March 2012, this Directive replaces the term ‘incidence’ with ‘prevalence’ in the description of endemic areas of HTLV-1/2 i ...
8 January 2021
Sequencing enabled the world to rapidly identify SARS-CoV-2 and develop diagnostic tests and other tools for outbreak management. Continued genome sequencing supports the monitoring of the disease’s spread and evolution of the virus
...
Laboratory manual for yellow fever
recommended
This WHO laboratory manual provides the most up to date methods and procedures for the laboratory identification of yellow fever virus infection in humans. It provides guidance on the establishment and maintenance of an effective laboratory providin
...
Weekly epidemiological update on COVID-19, 28 September 2022
What are the variants circulating at this time? How are variants classified as variants of interest or concern? What does this mean for the public?
...
It is recommended that egg based quadrivalent vaccines for use in the 2019-2020 northern hemisphere influenza season contain the following:
an A/Brisbane/02/2018 (H1N1)pdm09-like virus;
an A(H3N2)
...
Rabies is a fatal viral zoonosis and serious public health problem.1 All mammals are believed to be susceptible to the disease, and for the purposes of this document, use of the term animal refers to mammals. The disease is an acute, progressive encephalitis caused by viruses in the genus Lyssavirus
...
While COVID-19 virus continues to circulate and evolve, new variants are constantly emerging. Most of the current COVID-19 cases are driven by the circulation of the BA.5 subvariant of Omicron. The
...
Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when o
...
21 January 2022
The overall threat posed by Omicron largely depends on four key questions: (i) how transmissible the variant is; (ii) how well vaccines and prior infection protect against infection, transmission, clinical disease and death; (iii) how virulent the variant is compared to other
...
Lorsqu’un virus circule largement dans une population et entraîne de nombreuses infections, la probabilité de mutation augmente. Plus un virus a de possibilités de se propager, plus il se répl
...
